Mr. Higgins brings extensive commercial experience with a focus in oncology and rare diseases. He has a proven track record of commercial success, including commercial operations, strategic planning, launch and sales achievement across the full product life cycle. Previous positions include President and General Manager at Kyowa Kirin, Inc. (formerly ProStrakan Inc.), where he led the oncology-focused US commercial organization to profitability, Head of Marketing and launch lead for naproxcinod at NicOx and Executive Director of Oncology Marketing at Cytogen (now Jazz Pharmaceuticals). Mr. Higgins also held various positions of increasing commercial responsibility at AstraZeneca and Baxter. His consulting work includes strategic launch planning for checkpoint inhibitors and targeted therapies across a range of tumor types. He earned his bachelor’s degree from Villanova University.
President & Chief Executive Officer
Chief Medical Officer
Chief Manufacturing Officer
VP, Regulatory Affairs
VP, Clinical Development
SVP, Human Resources & Administration
Chief of Staff and Director, Program Management